Stay updated on Expanded Access of Lifileucel in Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Expanded Access of Lifileucel in Melanoma: Clinical Trial page.

Latest updates to the Expanded Access of Lifileucel in Melanoma: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new Revision: v3.4.2 entry was added; the previous funding notice and Revision: v3.4.1 were removed.SummaryDifference0.4%

- Check21 days agoChange DetectedNotice: a general funding-status banner and a new version identifier (Revision: v3.4.1) were added; core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdditions include Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0; Deletions include Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedUpdated Revision: v3.3.4 replaces the previous Revision: v3.3.3 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a Locations section listing study sites by state and updated the revision to v3.3.3.SummaryDifference3%

- Check91 days agoChange DetectedRevision: v3.3.2 from v3.2.0. This appears to be a page version update rather than a modification to study details or content.SummaryDifference0.0%

Stay in the know with updates to Expanded Access of Lifileucel in Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Expanded Access of Lifileucel in Melanoma: Clinical Trial page.